Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Groupe Dubreuil Air Division Embraces Digital Transformation
- Cango Inc. Shares Impressive Third Quarter Financial Results
- WuXi Biologics Expands Strategic Collaborations in the Middle East
- WuXi Biologics Expands Global Manufacturing Footprint in Qatar
- Kia America Achieves Record-Breaking November Performance
- Discover 11 Top S&P 500 Stocks Poised for Success This December
- Viridien's Voting Rights: Insights into Shareholder Power
- Steve Fulton Takes Helm at Orbus Software for New Growth Era
- Tom Lee Expects S&P 500 to Touch 7,300 Amid Positive Trends
- Max Keiser Unveils Bitcoin's Future: Focus on Long-Term Gains
- Power Metallic Mines Unveils Promising Drill Results and Plans
- Intellistake Expands AI Infrastructure with Space Initiative
- Xeltis Secures €50M Financing to Advance Innovative Hemodialysis Solutions
- Equiti Group Partners with TraderEvolution to Enhance Trading
- Munters Secures 82 MUSD Order for Advanced Chillers
- Moody's Mark Zandi Warns of AI Debt Crisis in Credit Markets
- Revolutionizing Rural Healthcare: Summit Pacific's Approach
- Munters Secures $82M Chiller Order for Cutting-Edge AI Data Center
- Brightstar Lottery PLC Announces Exciting Senior Notes Offering
- Global Market Dynamics Change Amid Economic Concerns
- ING Partners with Broadcom to Enhance Cloud Infrastructure
- Virtune Expands into Norway with Petter Northug as Ambassador
- Tuvalor Exchange Launches Initiative for Transparent Operations
- Equiti Group Innovates Trading Solutions Through Key Alliance
- Equiti Group Expands Trading Solutions with Strategic Alliance
- Droit Elevates European Strategy with New Sales Director
- Power Metallic Mines Announces Major Copper Intercepts at Lion
- Enhancing Aviation Safety: Real-Time Strategies to Stay Connected
- XM Achieves SCA License: A New Chapter in UAE Operations
- December Market Insights: Analyzing Price Trends for 2025
- How Google’s TPU Strategy Shifts the AI Cloud Landscape
- Healthcare Sector Surges Amid Market Weakness in November
- Is Now the Right Time to Invest in Nvidia After November Dip?
- Meta Platforms’ Stock Recovery Despite Weak Technical Outlook
- Municipality Finance Shares Removed from Trading at Nasdaq Helsinki
- Municipality Finance Successfully Launches EUR 100 Million Notes
- Strategic Partnership to Enhance PET Biorecycling in Asia
- Virtune Updates on MarketVector's Pricing Changes for ETPs
- Enefit Green Sells Tolpanvaara Wind Farm, Focuses on Growth
- Starbucks Faces $38 Million Penalty Over Labor Violations
- Bitget Engages with Youth Through LALIGA’s Football Event
- Ohanian's Vision: AI Revolutionizing Productivity in Business
- Speculations on Strategy Inc.'s Bitcoin Holdings and Market Moves
- Virtune Announces Key Update on Pricing Source for ETPs
- Essity Unveils New Business Structure for Future Growth
- Essity's Business Categories Restructure: A Comprehensive Overview
- Taiwan Design Week 2025: Shaping a Future Through Design
- Essity Restructures Business Areas for Enhanced Growth Strategy
- Navigating the S&P 500: Returns and Future Predictions
- Foresight Group's Successful Share Buyback Initiative Details
